• 0Shopping Cart
ARTES Biotechnology
  • Home
  • About us
      • Fine Art of Biotechnology
      • Management
      • Careers
      • ARTES VLP Vaccine Technology
      • Celebrating 20 years
      • Celebrating 15 years
      • History
      • Partner & Licensees
      • Contact
  • Offer
      • Cell Line Development
      • Process Development
      • Manufacturing
      • Technology Transfer
  • Platform Technology
    • Expression Technology
      • Yeast
      • Bacteria
    • Vaccine Technology
      • METAVAX®
      • SplitCore
  • Applications
      • Biopharmaceuticals
      • Biocatalysts
      • Cosmetics
      • Enzymes
      • Veterinary
  • Products
      • Biosimilars Technologies
      • Enzymes
      • Proteins for Diagnostics
      • Vaccines Technologies
  • News
  • Publications
  • Menu Menu

from left to right: Volker Jenzelewski, Michael Weniger, Ruth Maas, Melanie Piontek, Michael Piontek

Dr. Michael Piontek (Managing Director)

Michael Piontek is founder of ARTES and Managing Director. He has more than 20 years experience in contract R&D, process development and company management. Formerly he was Head of Process Development and Managing Director at Rhein Biotech GmbH. In this time, he was responsible for process and product development as well as for technology transfer of production processes in Europe, Asia, South America and North Africa.

P: +49 (0) 2173 27587-11
M: +49 (0) 173 213 26 15
E: michael.piontek(at)artes-biotechnology.com

Dr. Melanie Piontek (Business Development Director)

Melanie Piontek holds a PhD in biology and is specialized in protein chemistry. She is in charge of business development for ARTES since 2006. Before that, she worked 8 years in regional development companies and technology transfer agencies with the focus on supplying biotech companies with marketing and networking opportunities, as well as with business development support.

P: +49 (0) 2173 27587–12
M: +49 (0) 177 501 47 48
E: melanie.piontek(at)artes-biotechnology.com

Dipl.-Biol. Volker Jenzelewski (Director Technology)

Volker Jenzelewski holds a degree in biology and started his professional career in 1993 at RheinBiotech GmbH. Assuming positions of increasing responsibility in technical management and GMP-manufacturing he was finally directing process development and heading GMP manufacturing. In 2010 he stepped into the field of advanced therapy medicinal products as Managing Director of EUFETS GmbH, an internationally operating CDMO. In 2014 he joined ARTES Biotechnology GmbH as Director of Technology.

P: +49 (0) 2173 27587 -19

M: + 49 (0) 152 54715382
E: volker.jenzelewski(at)artes-biotechnology.com

Dipl.-Ing. Michael Weniger (Head of Process Development)

Michael Weniger holds a degree as Graduate Engineer Biotechnology/Biochemistry. Formerly he was Project Leader and Senior Engineer Process Development at Rhein Biotech GmbH. He was involved in successful technology transfer of cGMP production processes to South America, Korea and Egypt.

His experience are in the field of up- and downstream processing of bacterial processes, optimization of fermentation processes with subsequent development of protein isolation and purification strategies until generation of purified final bulk. He has experience in cGMP production of a Phase IIIa product and deep know how in qualification (DQ/IQ/OQ) and validation (PQ, cleaning validation) of equipment and process with the appropriate cGMP documentation.

P: +49 (0) 2173  27587 -20
E: michael.weniger(at)artes-biotechnology.com

Dr. Ruth Maas (Head of Molecular Biology)

Dr. Ruth Maas joined ARTES in May 2020 and since September this year she is heading the department of Molecular Biology. Ruth Maas holds a PhD from the Department of Microbiology/Biotechnology of the University Tübingen and has almost 30 years of experience with recombinant expression technologies in different microbial host systems. Before joining ARTES, she was involved as a Cofounder and Manager in various positions in two biotechnology start-up companies, Pharmacelsus GmbH and Autodisplay Biotech GmbH.

P: +49 (0) 2173  27587 -15
E: ruth.maas(at)artes-biotechnology.com

© Copyright - ARTES Biotechnology GmbH
  • Disclaimer
  • Privacy
  • Imprint
Scroll to top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT